HRTX - Heron Therapeutics GAAP EPS of -$0.54 beats by $0.04 revenue of $20.66M misses by $5.11M February, 28 2022 04:20 PM Heron Therapeutics Inc. Heron Therapeutics press release (NASDAQ:HRTX): Q4 GAAP EPS of -$0.54 beats by $0.04. Revenue of $20.66M (+0.2% Y/Y) misses by $5.11M. For further details see: Heron Therapeutics GAAP EPS of -$0.54 beats by $0.04, revenue of $20.66M misses by $5.11M